Literature DB >> 588376

Metabolic and hormonal studies in patients with essential hypertension.

W Januszewicz, M Ciswicka-Sznajderman, B Wocial, M Sznajderman, H Ignatowska-Switalska, H Berent, Z Zukowska-Grojec, T Feltynowski.   

Abstract

In 106 patients with essential hypertension and different plasma renin activity several hormonal and metabolic factors were studied: urinary excretion of catecholamines, blood levels of cholesterol and triglycerides, levels of glycaemia and insulinaemia after glucose load and plasma fibrinolytic activity. The plasma renin activity in 46.2 percent of patients was normal, whereas in 25.5 percent it was low, and in 28.3 percent it was high. In patients with high plasma renin activity the excretion of noradrenaline and adrenaline was relatively high while that of dopamine was low. Significantly lower triglyceride levels were found in patients with low plasma renin activity in comparison with those with high and normal plasma renin activity. There was also a statistically significant difference in the euglobulin lysis time which was shorter in patients with low and longest in patients with normal plasma renin activity. The results of the study show that patients with different plasma renin activity may also differ in some hormonal and metabolic values.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588376      PMCID: PMC483397          DOI: 10.1136/hrt.39.11.1205

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Improved technique for the fluorimetric estimation of catecholamines.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1961-04

2.  Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.

Authors:  G R FEARNLEY; G BALMFORTH; E FEARNLEY
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

3.  Neurogenic factors in human hypertension: mechanism or myth?

Authors:  V DeQuattro; Y Miura
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

4.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

5.  Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension.

Authors:  W J Mroczek; F A Finnerty; K J Catt
Journal:  Lancet       Date:  1973-09-01       Impact factor: 79.321

6.  In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP.

Authors:  A M Michelakis; J Caudle; G W Liddle
Journal:  Proc Soc Exp Biol Med       Date:  1969-03

7.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

8.  Fibrinolytic activity and coronary-artery disease.

Authors:  R Chakrabarti; E D Hocking; G R Fearnley; R D Mann; T N Attwell; D Jackson
Journal:  Lancet       Date:  1968-05-11       Impact factor: 79.321

9.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15

10.  Dopa, catecholamines and their metabolites in essential hypertension.

Authors:  W Januszewicz; B Wocial
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.